• Info
  • Insider Ownership

Insider Trading & Ownership of Peter Salzmann

Location
New York, NY
Summary
The estimated net worth of Peter Salzmann is at least $17,640,586 dollars as of 17 Apr 2025. Peter Salzmann is the Chief Executive Officer, Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $17.54M. Peter Salzmann is the Director of Corbus Pharmaceuticals Holdings, Inc. and owns shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock worth about $97.3K.
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Peter Salzmann
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Peter Salzmann and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Peter Salzmann has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $17,640,586.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Immunovant, Inc. ($17,543,264).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Peter Salzmann

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMVT Immunovant, Inc. Chief Executive Officer, Director $17,543,264 16 Apr 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Director $97,322 30 May 2024

Insider Transactions Reported by Peter Salzmann:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.